AAIC 2025 Abstract·26 DecExploratory CSF proteomic analysis of a pre‐specified pTau217 subgroup from the SHINE clinical trial identifies biomarkers correlated with cognitive improvement in Alzheimer’s disease patients treated with zervimesineTrial in peopleInterventionsPaper